These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31102571)

  • 1. Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer.
    Tonttila PP; Ahtikoski A; Kuisma M; Pääkkö E; Hirvikoski P; Vaarala MH
    BJU Int; 2019 Dec; 124(6):992-998. PubMed ID: 31102571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.
    Cai Q; Costa DN; Metter CK; Goldberg K; Roehrborn CG; Cadeddu J; Pedrosa I; Meng X; Mostardeiro TR; Shah RB
    Urol Oncol; 2022 Oct; 40(10):452.e1-452.e8. PubMed ID: 36008255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cribriform morphology impairs Gleason 7 prostate cancer lesion detection on multiparametric magnetic resonance imaging.
    Kazan O; Gunduz N; Kir G; Iplikci A; Dogan MB; Cecikoglu GE; Culpan M; Yildirim A
    Prostate; 2023 Mar; 83(4):331-339. PubMed ID: 36477738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The visibility of prostate cancer concerning underlying histopathological variances: A single-center multiparametric magnetic resonance imaging study.
    Arslan A; Alis D; Tuna MB; Sağlıcan Y; Kural AR; Karaarslan E
    Eur J Radiol; 2021 Aug; 141():109791. PubMed ID: 34062471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer.
    Bernardino RM; Sayyid RK; Lajkosz K; Al-Daqqaq Z; Cockburn JG; Chavarriaga J; Abedi S; Leão R; Berlin A; van der Kwast T; Fleshner NE
    Eur Urol Focus; 2024 Jan; 10(1):146-153. PubMed ID: 37696743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN study.
    Tohi Y; Ishikawa R; Kato T; Miyakawa J; Matsumoto R; Mori K; Mitsuzuka K; Inokuchi J; Matsumura M; Shiga K; Naito H; Kohjimoto Y; Kawamura N; Inoue M; Kinoshita H; Hashimoto K; Goto K; Haba R; Kakehi Y; Sugimoto M
    Int J Clin Oncol; 2023 Feb; 28(2):299-305. PubMed ID: 36472710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer.
    Ghai S; Klotz L; Pond GR; Kebabdjian M; Downes MR; Belanger EC; Moussa M; van der Kwast TH
    Radiology; 2024 Jul; 312(1):e231948. PubMed ID: 39012252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cribriform Pattern of The Prostate Adenocarcinoma: Sensitivity of Multiparametric MRI.
    Tuna MB; Arslan A; Kök YB; Doganca T; Argun OB; Tufek I; Pirdal BZ; Saglican Y; Obek C; Karaarslan E; Kural AR
    Urol J; 2022 Dec; 20(1):34-40. PubMed ID: 36528799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study.
    Kam J; Yuminaga Y; Krelle M; Gavin D; Koschel S; Aluwihare K; Sutherland T; Skinner S; Brennan J; Wong LM; Louie-Johnsun M
    BJU Int; 2019 Aug; 124(2):297-301. PubMed ID: 30714285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors.
    Gaudiano C; Bianchi L; De Cinque A; Corcioni B; Giunchi F; Schiavina R; Fiorentino M; Brunocilla E; Golfieri R
    Radiol Med; 2022 Feb; 127(2):174-182. PubMed ID: 34850354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
    Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
    J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern.
    van der Slot MA; Seyrek N; Kweldam CF; den Bakker MA; Busstra MB; Gan M; Klaver S; Rietbergen JBW; van Leenders GJLH
    World J Urol; 2022 Nov; 40(11):2723-2729. PubMed ID: 36190529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of seminal vesicle invasion on preoperative multi-parametric magnetic resonance imaging in pathological stage T3b prostate cancer.
    Kim JK; Lee HJ; Hwang SI; Choe G; Hong SK
    Sci Rep; 2020 Mar; 10(1):5693. PubMed ID: 32231265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-detectability and histological factors of prostate cancer including intraductal carcinoma and cribriform pattern.
    Mikoshi A; Miyai K; Hamabe F; Edo H; Ito K; Matsukuma S; Tsuda H; Shinmoto H
    Prostate; 2022 Mar; 82(4):452-463. PubMed ID: 34964158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
    Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T
    Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
    Deniffel D; Salinas E; Ientilucci M; Evans AJ; Fleshner N; Ghai S; Hamilton R; Roberts A; Toi A; van der Kwast T; Zlotta A; Finelli A; Haider MA; Perlis N
    J Urol; 2020 Dec; 204(6):1187-1194. PubMed ID: 32496160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
    Sandeman K; Eineluoto JT; Pohjonen J; Erickson A; Kilpeläinen TP; Järvinen P; Santti H; Petas A; Matikainen M; Marjasuo S; Kenttämies A; Mirtti T; Rannikko A
    PLoS One; 2020; 15(7):e0235779. PubMed ID: 32645056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy.
    Lee H; Kim CK; Park BK; Sung HH; Han DH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    World J Urol; 2017 Jun; 35(6):929-934. PubMed ID: 27738805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.